Oregon Public Employees Retirement Fund Purchases 501 Shares of CME Group Inc (CME)

Oregon Public Employees Retirement Fund grew its position in shares of CME Group Inc (NASDAQ:CME) by 0.6% in the third quarter, Holdings Channel reports. The fund owned 87,193 shares of the financial services provider’s stock after acquiring an additional 501 shares during the period. Oregon Public Employees Retirement Fund’s holdings in CME Group were worth $14,841,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. Meeder Asset Management Inc. boosted its holdings in shares of CME Group by 84.8% in the 2nd quarter. Meeder Asset Management Inc. now owns 789 shares of the financial services provider’s stock valued at $129,000 after buying an additional 362 shares during the last quarter. Kaizen Advisory LLC boosted its holdings in shares of CME Group by 151.9% in the 2nd quarter. Kaizen Advisory LLC now owns 816 shares of the financial services provider’s stock valued at $134,000 after buying an additional 492 shares during the last quarter. Sun Life Financial INC boosted its holdings in shares of CME Group by 267.7% in the 2nd quarter. Sun Life Financial INC now owns 923 shares of the financial services provider’s stock valued at $151,000 after buying an additional 672 shares during the last quarter. Cornerstone Wealth Management LLC acquired a new stake in shares of CME Group in the 2nd quarter valued at approximately $153,000. Finally, Buckley Wealth Management LLC acquired a new stake in shares of CME Group in the 3rd quarter valued at approximately $201,000. 84.29% of the stock is owned by hedge funds and other institutional investors.

Shares of CME Group stock opened at $182.75 on Wednesday. CME Group Inc has a 1 year low of $135.61 and a 1 year high of $183.79. The firm has a market cap of $60.65 billion, a price-to-earnings ratio of 38.25, a price-to-earnings-growth ratio of 3.38 and a beta of 0.64. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.08.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, October 25th. The financial services provider reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.03. CME Group had a return on equity of 9.18% and a net margin of 113.67%. The business had revenue of $904.20 million during the quarter, compared to the consensus estimate of $910.50 million. On average, sell-side analysts forecast that CME Group Inc will post 6.63 EPS for the current fiscal year.

Several equities research analysts have recently commented on the company. Wells Fargo & Co increased their price objective on CME Group from $175.00 to $177.00 and gave the company a “market perform” rating in a report on Friday, October 26th. Deutsche Bank reissued a “buy” rating and issued a $192.00 price objective (up previously from $185.00) on shares of CME Group in a report on Thursday, October 11th. BidaskClub raised CME Group from a “buy” rating to a “strong-buy” rating in a report on Tuesday, October 9th. Jefferies Financial Group increased their price objective on CME Group to $203.00 and gave the company a “buy” rating in a report on Monday, October 8th. Finally, Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a report on Wednesday, October 3rd. Five analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $181.54.

In other CME Group news, President Bryan T. Durkin sold 11,509 shares of the stock in a transaction on Monday, August 6th. The stock was sold at an average price of $162.01, for a total transaction of $1,864,573.09. Following the transaction, the president now owns 64,862 shares in the company, valued at approximately $10,508,292.62. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Ronald A. Pankau sold 260 shares of the stock in a transaction on Thursday, August 9th. The stock was sold at an average price of $163.17, for a total value of $42,424.20. Following the transaction, the director now owns 3,900 shares in the company, valued at approximately $636,363. The disclosure for this sale can be found here. Insiders have sold a total of 29,188 shares of company stock valued at $4,973,607 in the last ninety days. Insiders own 0.43% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Recommended Story: Penny Stocks, Risk and Reward Factors

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply